2023
Genital tuberculosis, infertility and assisted reproduction
Mir N, Pal L. Genital tuberculosis, infertility and assisted reproduction. Current Opinion In Obstetrics & Gynecology 2023, 35: 263-269. PMID: 36912346, DOI: 10.1097/gco.0000000000000866.Peer-Reviewed Original ResearchConceptsGenital tuberculosisClinical presentationLife-threatening risksGenital TBFetal morbidityInfertile womenCouple infertilityAppropriate screeningTimely treatmentRisk populationsUntreated casesInfertilityAssisted reproductionReproductive technologiesUnique risksTuberculosisRiskPresentationMorbidityIVFEpidemiologyDiagnosisRecent literatureWomen
2021
Chronic endometritis: A prevalent yet poorly understood entity
Margulies SL, Flores V, Parkash V, Pal L. Chronic endometritis: A prevalent yet poorly understood entity. International Journal Of Gynecology & Obstetrics 2021, 158: 194-200. PMID: 34605024, DOI: 10.1002/ijgo.13962.Peer-Reviewed Original ResearchConceptsChronic endometritisExact testCross-sectional observational studyEvidence-based consensusObstetrician/gynecologistsFisher's exact testSpectrum of deficienciesGood clinical practiceChi-square testAnonymous electronic surveyClinical presentationUnderappreciated burdenTreatment strategiesObservational studyPrevalent conditionDiagnostic criteriaEndometritisClinical practiceClinical implicationsSquare testEndometritis diagnosisConfidence intervalsHealthcare systemPrevalent inconsistenciesElectronic survey
2019
Chronic Endometritis: A Prevalent Yet Poorly Understood Entity [23H]
Margulies S, Flores V, Parkash V, Pal L. Chronic Endometritis: A Prevalent Yet Poorly Understood Entity [23H]. Obstetrics And Gynecology 2019, 133: 90s-90s. DOI: 10.1097/01.aog.0000558762.97122.17.Peer-Reviewed Original ResearchChronic endometritisOB/GYNsHistological criteriaProviders' understandingProspective observational studyStandard of careObstetrician/gynecologistsAnonymous electronic surveyInfectious etiologyClinical presentationGynecologic conditionsObservational studyDiagnostic criteriaInfectious agentsAntimicrobial treatmentPatient careClinical implicationsPathophysiologyLack of consensusPathologistsElectronic surveyTreatmentGYNsCareTask Force
2017
Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature.
Gressel G, Buza N, Pal L. Ovarian Sertoli-Leydig cell tumors: a single institution experience and review of the literature. European Journal Of Gynaecological Oncology 2017, 38: 214-220. PMID: 29953783.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantDisease-Free SurvivalFemaleHumansHyperandrogenismHysterectomyMiddle AgedNeoadjuvant TherapyNeoplasm GradingOvarian NeoplasmsOvariectomyPostmenopauseRetrospective StudiesSalpingectomySertoli-Leydig Cell TumorConceptsSertoli-Leydig cell tumorOvarian Sertoli-Leydig cell tumorPresent patient populationDisease-free survivalSingle institution experienceTertiary care institutionTime of diagnosisOnset of menopauseRisk of recurrenceSeries of casesAdjuvant chemotherapyMedian followPostmenopausal bleedingPostmenopausal patientsMedian ageMedian intervalClinical presentationDefinitive managementPathological findingsRetrospective reviewInstitution experiencePatient populationTreatment modalitiesCell tumorsTumor grade